Henry Schein (HSIC) has been spotted in recent news for a variety of reasons. The firm has made proactive efforts to boost dental careers in underrepresented communities, a move facilitated by the National Dental Association and Schattner Foundation. Financial estimates for HSIC's third quarter 2024 are being reduced by Zacks Research. Macroeconomic troubles and cyber threats have reportedly affected the company, resulting in HSIC shares dropping to $72.16. Furthermore, HSIC's 2024 guidance was recently slashed post second-quarter earnings surpassing expectations. Initiatives like the 27th Annual “Back to School” Program were noted to empower students worldwide. However, HSIC stock has seen a 4.3% downfall post the last earnings report.
HSIC has completed the acquisition of a majority interest of TriMed, Inc. this has extended its reach into the orthopedics market. However, a lingering impact is noted from a past cyber-attack for which the annual profit forecast was trimmed. HSIC's acquisition strategy has faced criticism for not pulling its economic weight despite several purchases. HSIC’s stock, despite a hit by the impact of a cyberattack, is seen as a 'Moderate Buy' by brokerages. Considering the news updates, HSIC's future growth prospects and innovations seem to be a mix of strategic failures and triumphs.
Henry Schein HSIC News Analytics from Mon, 11 Oct 2021 07:00:00 GMT to Sun, 01 Sep 2024 12:14:31 GMT - Rating 4 - Innovation 6 - Information 5 - Rumor -2
